Spruce Biosciences, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | +413.7% | -51.3% | -100.0% | |
| – | +1,100.0% | +750.0% | +273.5% | +12.6% | +11,422.6% | – | – | |
| – | – | – | – | – | – | -51.3% | -100.4% | |
| – | +28.7% | +120.5% | +28.7% | +14.7% | +40.4% | -6.1% | -57.9% | |
| – | +46.0% | +142.9% | +104.4% | +6.3% | +4.7% | +15.8% | +16.0% | |
| – | +31.4% | +124.4% | +43.0% | +12.4% | +31.3% | -1.6% | -40.2% | |
| – | – | – | – | – | – | – | – | |
| – | – | +396.9% | +6.8% | +21.7% | +15.0% | -36.4% | -70.7% | |
| – | – | – | – | – | – | – | – | |
| – | +30.7% | +226.8% | -18.7% | -378.5% | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.